These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 882712)

  • 21. Anomalous cell surface structure of sickle cell anemia erythrocytes as demonstrated by cell surface labeling and endo-beta-galactosidase treatment.
    Fukuda M; Fukuda MN; Hakomori S; Papayannopoulou T
    J Supramol Struct Cell Biochem; 1981; 17(3):289-97. PubMed ID: 6799655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro exposure to hydroxyurea reduces sickle red blood cell deformability.
    Huang Z; Louderback JG; King SB; Ballas SK; Kim-Shapiro DB
    Am J Hematol; 2001 Jul; 67(3):151-6. PubMed ID: 11391710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane protein organization in ATP-depleted and irreversibly sickled red cells.
    Palek J; Liu SC
    J Supramol Struct; 1979; 10(1):79-96. PubMed ID: 108478
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of sickling on dimyristoylphosphatidylcholine-induced vesiculation in sickle red blood cells.
    Bütikofer P; Chiu DT; Lubin B; Ott P
    Biochim Biophys Acta; 1986 Feb; 855(2):286-92. PubMed ID: 3947625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiologic and rheologic effects of the antisickling agent ethacrynic acid and its N-butylated derivative on normal and sickle erythrocytes.
    Orringer EP; Blythe DS; Whitney JA; Brockenbrough S; Abraham DJ
    Am J Hematol; 1992 Jan; 39(1):39-44. PubMed ID: 1536139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sickled erythrocytes: a model to study the stabilization of the phospholipid bilayer in the red cell membrane.
    Roelofsen B; Franck PF; Chiu DT; Lubin B; Van Deenen LL; Op den Kamp JA
    Biomed Biochim Acta; 1983; 42(11-12):S22-6. PubMed ID: 6675694
    [No Abstract]   [Full Text] [Related]  

  • 27. Letter: Plasma-zinc in sickle cell-anaemia.
    Karayalcin G; Rosner F; Kim KY; Chandra P
    Lancet; 1974 Feb; 1(7850):217. PubMed ID: 4129898
    [No Abstract]   [Full Text] [Related]  

  • 28. Localization and role of calcium in the erythrocyte coat: effects of enzymes and storage.
    Frisch B; Lewis SM
    Br J Haematol; 1978 Dec; 40(4):541-50. PubMed ID: 728371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bepridil as an antisickling agent: membrane internalization and cell rigidity.
    Johnson RM; Acquaye C; Féo C; Sarnaik S
    Am J Hematol; 1994 Aug; 46(4):310-8. PubMed ID: 8037182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electron microscopic examination of common red cell ghosts: cytoplasmic contamination.
    Hazlewood CF; Singer DB; Beall PT
    Physiol Chem Phys; 1979; 11(2):181-4. PubMed ID: 482389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative charge distribution and density on the surface of oxygenated normal and sickle red cells.
    Clark LJ; Chan LS; Powars DR; Baker RF
    Blood; 1981 Apr; 57(4):675-8. PubMed ID: 7470618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membrane ultrastructural changes during calcium phosphate-induced fusion of human erythrocyte ghosts.
    Zakai N; Kulka RG; Loyter A
    Proc Natl Acad Sci U S A; 1977 Jun; 74(6):2417-21. PubMed ID: 329283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red blood cell [14C]cholesterol exchange and plasma cholesterol esterifying activity of normal and sickle cell blood.
    Jain SK; Shohet SB
    Biochim Biophys Acta; 1982 May; 688(1):11-5. PubMed ID: 7093267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug action hypothesis: how membrane expansion, calmodulin inhibition, and sickle cell therapy relate.
    Brewer GJ; Bereza U; Mizukami I; Aster JC; Brewer LF
    Prog Clin Biol Res; 1981; 55():187-211. PubMed ID: 6117079
    [No Abstract]   [Full Text] [Related]  

  • 35. Freeze-etch localization and distribution of concanavalin A in normal and irreversibly sickled erythrocytes.
    Wise GE; Shienvold FL; Rubin R; Milikowski C
    Tissue Cell; 1978; 10(2):219-25. PubMed ID: 675662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zinc in the treatment of homozygous sickle cell anemia: studies in an animal model.
    Schoomaker EB; Brewer GJ; Oelshlegel FJ
    Am J Hematol; 1976; 1(1):45-57. PubMed ID: 984036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane-associated sickle hemoglobin: a major determinant of sickle erythrocyte rigidity.
    Evans EA; Mohandas N
    Blood; 1987 Nov; 70(5):1443-9. PubMed ID: 3663941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased susceptibility of erythrocyte membrane lipids to peroxidation in sickle cell disease.
    Essien EU
    Cent Afr J Med; 1994 Aug; 40(8):217-20. PubMed ID: 7813000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The irreversibly sickled cell.
    Smith CM; Krivit W; White JG
    Am J Pediatr Hematol Oncol; 1982; 4(3):307-15. PubMed ID: 7149169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane alterations in irreversibly sickled cells: hemoglobin--membrane interaction.
    Lessin LS; Kurantsin-Mills J; Wallas C; Weems H
    J Supramol Struct; 1978; 9(4):537-54. PubMed ID: 750765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.